IMVT
Immunovant Inc
32.00$
-0.2%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +3.6% | +10.3% | +25.0% | +11.3% | +11.2% | +10.1% | -1.8% | -1.9% | -3.8% | -5.0% | -4.2% | – | |
| – | -2.9% | -5.3% | +39.0% | -5.7% | -8.2% | +0.3% | +58.4% | -27.8% | -4.8% | -12.4% | +23.6% | – | |
| – | – | – | -147.1% | – | -113.6% | – | – | – | -47.9% | +659.4% | -64.1% | – | |
| – | +285.3% | +14.5% | +21.3% | +7.7% | -8.2% | +11.7% | -100.0% | – | – | – | -100.0% | – | |
| – | +285.3% | +14.5% | +21.3% | +7.7% | -8.2% | +11.7% | – | – | – | – | – | – | |
| – | +317,362.2% | -99.7% | -55.6% | +6.4% | +237.5% | +18,187.8% | -99.4% | +742.9% | +2,195.6% | -99.4% | +452.1% | – | |
| – | – | -113.2% | – | – | – | – | -133.9% | – | – | -119.6% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.